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Conventional assays of omega-3 long chain polyunsaturated fatty acid (n-3 LCPUFA) 
status in humans involve venous blood collection and expensive, multi-step processes 
that limit their usefulness as screening tools. This study aimed to develop a capillary 
dried blood spot (DBS) system capable of protecting n-3 LCPUFA from oxidation for 
up to 2 months at room temperature (20-25°C). We demonstrated that a DBS system 
comprising both an antioxidant and chelating agent on silica-gel coated paper 
prevented any significant change in the n-3 LCPUFA profile after 2 months. Our DBS 
assay was then tested in fifty subjects, and this demonstrated the presence of strong 
and significant correlations between the results obtained from the DBS system and 
those obtained from conventional measures for all fatty acids, in particular the n-3 
LCPUFA EPA and DHA (r>0.96, P<0.0001). This study therefore validates our DBS 
























Increased consumption of omega-3 long chain polyunsaturated fatty acids (n-3 
LCPUFA) and the concomitant increase in n-3 LCPUFA concentrations in the 
circulation has been associated with a number of health benefits in humans, including 
prevention of preterm birth [1], primary and secondary protection against 
cardiovascular disease [2], and strengthened immune defences [3]. 
 
As a result of these health benefits, there is a growing interest in assessing the 
relationship between dietary n-3 fatty acid intake and LCPUFA status in human 
populations. There is particular interest in the bioactive n-3 LCPUFA 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the sum of which, 
termed the omega-3 index, has been proposed as a measure of risk for death from 
coronary heart disease [4, 5]. However, conventional approaches to assaying fatty 
acids in blood involve venous blood collection and an expensive, time consuming 
multi-step process that limit their usefulness as a screening tool.  
 
Attempts have been made to adopt the dried blood spot (DBS) technique as a quick, 
inexpensive and minimally invasive tool for measuring fatty acid status in humans [6-
9]. Nishio et al. described a rapid fatty acid assay using a DBS absorbed on filter 
paper to diagnose adrenoleukodystrophy, an X-linked metabolic disorder [6]. 
However, their study only focused on the levels of specific saturated fatty acid (SFA) 
biomarkers of adrenoleukodystrophy, including C22:0, C24:0 and C26:0 which are 
inherently stable in air [6].  Ichihara et al. described a method which utilised filter 
paper impregnated with the antioxidant, butylated hydroxytoluene (BHT), to collect 
blood or milk spots for the analysis of C20-C22 LCPUFA status [7]. However, the 
alkaline methylation conditions used in their study lacked the ability to transesterify 
free fatty acids, steryl esters and sphingolipids, limiting the usefulness of the method 
[7]. A widely quoted study by Marangoni et al. described an assay for rapid profiling 
of the fatty acids in whole blood using a filter paper based DBS [8], and the authors 
claimed that this method was sufficiently sensitive to detect changes in blood fatty 
acid levels due to various lifestyle and dietary factors [9]. However, the DHA values 
obtained using their DBS method differed from those obtained using a conventional 
whole blood fatty acid assay [8]. In addition, the potential fatty acid contaminants 
released from the collection papers [10], and evidence of substantial oxidative losses 
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of LCPUFA in DBS samples collected in this manner when stored in air [11] has led 
to concerns about the reliability of the method.  Due to the high sensitivity of 
LCPUFA to oxidation, previous studies have taken the approach of processing the 
DBS samples immediately after blood collection [12, 13], treating them with high 
levels of BHT [14] or storing them at -20°C to stabilise the LCPUFA [15]. However, 
none of these approaches fulfils the criteria for them to be considered as a stable and 
convenient clinical assay for large population studies, clinical trials or for pathology 
services. 
 
The objective of this study was to develop a DBS method that would allow samples to 
be stored at room temperature for at least 2 months without significant change in the 
LCPUFA profile and to validate the clinical application of our DBS method through a 
direct comparison with established methods. 
 
Materials and Methods 
Subjects  
Ethical approval for the collection of blood and body fluids for this study was 
obtained from The University of Adelaide Human Research Ethics Committee. All 
volunteers were fully informed of the nature of the study and provided written 
informed consent prior to blood collection. We undertook the initial development of 
our method using the blood of the donor who had consumed 15ml of MaxEPA fish oil 
daily for several years and had a very high blood content of EPA and DHA (each ~7% 
of the total fatty acids), since it was reasoned that blood from such a donor would 
provide the greatest opportunity of detecting even small losses in n-3 LCPUFA if they 
occurred. The final DBS method was evaluated in 50 subjects to establish the 
relationship between the fatty acid status obtained from our DBS method and 
traditional methods used to measure fatty acids in different blood fractions. In this 
study, blood samples were collected at the same clinic appointment both using the 
DBS system and through the antecubital vein from each of the 50 subjects (26 females 
and 24 males) aged between 22 and 71 years. The participants included 23 people 
who reported consuming relatively high amounts of fish oil supplements (≥3 gram per 
day), 14 people who reported seldom consuming any fish oil supplements (<1 gram 
per week) but had a regular consumption of fish (≥1 serving per week), and 13 people 
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who reported seldom consuming any fish (<1 serving per week) or fish oil 
supplements (<1 gram per week) (Table 1). The DBS method was further applied to 
plasma and breast milk samples donated by one healthy volunteer aged 33. 
 
Development of DBS method  
Blood collection papers 
Four types of papers were used for blood collection: Fluka blood collection paper 
(Sigma-Aldrich, Buchs, Switzerland), Whatman 903 specimen collection paper, 
Whatman 3MM chromatography paper, and Whatman ion exchange paper (46x57cm, 
Whatman, Buckingham, UK). The Fluka blood collection paper is currently part of a 
kit marketed by Sigma-Aldrich for the evaluation of n-3 and n-6 PUFA status in blood, 
thus, it was used as an industry standard to compare with the other papers. 
 
Protectants 
Two phenolic antioxidants, BHT, and tertiary butylhydroquinone (TBHQ) (Sigma-
Aldrich, St Louis, MO) at three concentrations (0.5mg/ml, 2mg/ml and 4mg/ml), and 
three chelating agents, L-ascorbic acid, citric acid, and ethylenediaminetetraacetic 
acid (EDTA) (Chem-supply, Gillman, Australia) at three concentrations (1mg/ml, 
5mg/ml and 20mg/ml) were tested separately or in combination in order to determine 
the optimal protectant concentration to limit lipid oxidation in DBS. 50µl of 
protectant solution was spread evenly onto the collection area (~1.5x1.5cm) of strips 
(~1.5x3cm) of each collection paper and air dried prior to collection of blood onto the 
paper. 
 
Fatty acids transesterification 
A baseline measurement for fatty acid status in whole blood was carried out using a 
modified direct transesterification method (16). Briefly, 50µl of fresh blood was 
added to 2ml of 1% (v/v) H2SO4 (18M AR grade, BDH, Sussex, UK) in anhydrous 
methanol (Merck, Darmstadt, Germany) in a 5ml sealed vial (Wheaton, Millville, 
USA), and heated at 70°C for 3 hrs. The resultant fatty acid methyl esters (FAME) 
were extracted into heptanes (Merck, Darmstadt, Germany). All the samples were 




Blood spot samples were obtained by absorbing a drop of fresh blood (~50 µl) onto 
the collection area (~1.5x1.5cm) of blood collection paper strips in the absence or 
presence of protectants, and all blood spots were dried in air at room temperature for 5 
hrs prior to processing. The whole dried blood spot was directly transmethylated 
following the same procedure as for the fresh blood either immediately after air 
drying, or after 1 week, 2 weeks, 3 weeks, 4 weeks or 9 weeks of storage at room 
temperature. In all experiments, the dried blood/plasma/breast milk spot samples were 
stored in cellophane bags in the dark and in the presence of desiccants. All samples 
were processed in triplicate. 
 
Clinical validation of the DBS method 
Blood and body fluids collection 
For the capillary samples, a drop of blood (~30µl) was collected from the thumb of 
each subject using an automatic lancing device (Unistick 2, Owen Mumford, UK). 
The blood was spotted onto the collection area of our blood collection paper, and air 
dried for 5 hrs at room temperature prior to fatty acid analysis.  
 
For the venous blood samples, ~6 ml of blood were drawn from an antecubital vein of 
the forearm into Vacutainer tubes containing heparin as an anticoagulant (Vacutte, 
Greiner Bio One, Austria). 500µl of venous whole blood was retained for total lipid 
extraction. The remainder of the venous whole blood sample (~5 ml) was centrifuged 
at 3200 rpm for 15 mins at 4°C to separate plasma and erythrocytes. The erythrocytes 
were then washed three times with 0.9% sodium chloride, and the buffy coat removed. 
Whole blood, plasma, and erythrocytes were stored at 4°C, and processed for fatty 
acid composition within 24 hrs of blood collection.  
 
Fatty acid analysis of DBS samples 
The transesterification of lipids in DBS samples was carried out using the method 
described in the DBS method development section above. 
 
Conventional fatty acid analysis of blood fractions 
Total lipids from whole blood, plasma, and erythrocytes were extracted using a 
modified Folch method [16]. Briefly, total lipids from whole blood, plasma, and 
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erythrocytes were extracted by chloroform/methanol (2:1, v/v). After addition of the 
chloroform/methanol, the sample was shaken vigorously and allowed to stand at room 
temperature for 5 mins. The sample was then centrifuged at 3000 rpm for 10 mins to 
separate the aqueous and organic phase. The organic layer which contained the total 
lipids extract was transferred into a scintillation vial (Wheaton, USA) and evaporated 
to dryness under a steady nitrogen stream. 
 
The phospholipid fraction of plasma and erythrocytes was separated from total lipids 
by one dimensional thin layer chromatography [17] using Silica gel 60H plates 
(Merck, Darmstadt, Germany). A petroleum spirit/acetone (3:1, v/v) solution was 
used as the mobile phase for phospholipid separation. The phospholipid band was 
visualized under ultraviolet light and scraped into scintillation vials for fatty acid 
transesterification. FAME were prepared from whole blood total lipids, plasma total 
lipids, plasma phospholipids, and erythrocyte phospholipids using the same 
transesterification method as described above for DBS samples. The resultant FAME 
were extracted into heptane, and injected into a Gas chromatography for analysis. 
 
Gas Chromatography Analysis 
FAME were separated and quantified using a Gas Chromatograph (Hewlett-Packard 
6890; Palo Alto, CA, USA) equipped with a BPX70 capillary column 50m x 0.32mm, 
film thickness 0.25µm (SGC Pty Ltd., Victoria, Australia), programmed temperature 
vaporization injector and a flame ionisation detector (FID). The injector temperature 
was set at 250°C and the FID temperature at 300°C, a programmed temperature ramp 
(140-240°C) was used. Helium gas was utilised as a carrier at a flow rate of 35 cm per 
second in the column and the inlet split ratio was set at 20:1. The identification and 
quantification of FAME was achieved by comparing the retention times and peak area 
values of unknown samples to those of commercial lipid standards (Nu-Chek Prep 
Inc., Elysian, MN, USA) using the Hewlett-Packard Chemstation data system [17]. 
 
Statistical Analyses 
All statistical analyses were conducted using PASW Statistic 18. Values for 
individual fatty acids are expressed as a percentage of total blood fatty acids, and 
presented as mean ± standard deviation (SD). The main effects and interactions of 
paper type, protectant formulation, and storage periods in relation to the changes in 
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fatty acid composition were determined using three-way ANOVA. Where significant 
interactions between protectant formulations and paper type over time were 
determined by multi-factorial ANOVA, significant differences in fatty acids 
percentage between protectant formulations within each paper type was determined at 
each storage period by one-way ANOVA with comparison of individual means by 
Tukey’s post-hoc test. Due to the number of statistical comparisons made, p<0.01 was 
chosen as the level of statistical significance. Spearman’s rank correlation coefficient 
was calculated to determine the strength of the association between capillary DBS 
fatty acid values and the corresponding fatty acid values in various lipid fractions 
from venous blood. 
 
Results 
Stability of DBS absorbed on different types of collection papers 
Regardless of the collection paper used, significant decreases in percentages of 
arachidonic acid (AA), EPA and DHA in DBS samples were observed over 4 weeks 
of storage at room temperature, despite the fact that the papers had been impregnated 
with BHT (Figure 1). There was no significant difference in the fatty acid 
composition of the DBS between samples collected on Fluka blood collection paper, 
Whatman 3MM paper, and Whatman 903 paper at any time point over the storage 
period. However, the DBS samples collected on Whatman ion exchange paper 
exhibited a lower decline in the levels of all LCPUFA when compared to those DBS 
collected on other types of papers following 4 weeks of storage at room temperature 
(Figure 1). 
 
Stability of n-3 LCPUFA in DBS treated with a single antioxidant or a single 
chelating agent 
Blood spots collected on Fluka blood collection paper or Whatman ion exchange 
paper in the absence or presence of a single antioxidant or a single chelating agent 
were analysed for fatty acid status either immediately after air drying (5 hrs), or after 





The results are expressed as the sum of EPA+DHA level in total blood fatty acids, as 
these n-3 LCPUFA showed the greatest sensitivity to oxidation, and the sum of 
EPA+DHA, termed the omega-3 index, has been proposed as a measure of risk for 
death from coronary heart disease [4]. DBS collected on Whatman ion exchange 
papers consistently exhibited higher residual levels of n-3 LCPUFA when compared 
with the DBS samples collected on Fluka papers irrespective of the protectant 
formulations used (Figures 2-3). 
 
Equivalent concentrations of BHT and TBHQ showed similar abilities to retard the 
decline of n-3 LCPUFA levels in DBS collected on Fluka paper over the 4 weeks of 
storage (Figure 2). However, the DBS collected on BHT impregnated Whatman ion 
exchange paper retained a higher level of n-3 LCPUFA than those collected on TBHQ 
impregnated Whatman ion exchange paper at all three antioxidant concentrations 
(Figure 2). BHT and TBHQ at a concentration of 2mg/ml exhibited a significantly 
improved capacity for protection of n-3 LCPUFA levels over the 4 weeks of storage 
than those samples collected on papers impregnated with 0.5mg/ml of the same 
antioxidant (Figure 2). Further increasing the BHT or TBHQ concentration to 4mg/ml 
did not result in any further improvements in the level of n-3 LCPUFA retained in 
DBS after storage (Figure 2).  
 
In order to protect against potential oxidative effects of free iron from red blood cells 
we tested a range of chelating agents. Regardless of the type of chelating agent used, 
the blood samples collected on papers impregnated with either of the chelating agents 
at a concentration of 5mg/ml showed significantly higher residual n-3 LCPUFA 
content than the samples collected on papers impregnated with 1mg/ml of the 
chelating agent after 4 weeks of storage (Figure 3). Further increasing the chelating 
agent concentration to 20mg/ml did not result in any further improvements in the level 
of n-3 LCPUFA retained in DBS after storage (Figure 3).  
 
As a result, BHT at a concentration of 2mg/ml and chelating agent at a concentration 




Stability of DBS treated with a mixture of an antioxidant and a chelating agent over 
time 
Blood spots collected on Fluka blood collection paper and Whatman ion exchange 
paper in the absence or presence of BHT, or a mixture of BHT and a chelating agent 
(Table 2) were analysed for fatty acid status either immediately after air drying (5 hrs), 
or after 2 weeks, 4 weeks or 9 weeks storage at room temperature in cellophane bags 
as previously described.  
 
 
Even after 5 hrs of air drying at room temperature, there was a significant reduction in 
the levels of all n-3 LCPUFA in the DBS collected on both types of collection papers 
which had not been treated with any protectant compared to those measured when 
whole blood was directly transmethylated before drying (Table 2). Significant 
declines in the levels of EPA and DHA were also detected in DBS samples which 
were collected on either of the collection papers treated with BHT alone when 
compared with those measured from fresh blood by direct transesterification (Table 2). 
However, the fatty acid levels measured in DBS collected on papers impregnated with 
a mixture of BHT and either of the chelating agents  (L-ascorbic acid, citric acid or 
EDTA) were not significantly different from the results obtained from fresh blood, 
irrespective of the type of collection paper used (Table 2). 
 
During storage, there was a significant interaction between paper type and protectant 
formulation in relation to fatty acid composition, such that protectant formulations on 
different types of paper showed different stabilising ability. DBS collected on 
Whatman ion exchange paper consistently exhibited a fatty acid composition that was 
more similar to that in fresh blood when compared with DBS collected on Fluka paper, 
irrespective of the protectant formulation used or the storage period (Figure 4).  
 
After 9 weeks of storage at room temperature, irrespective of the protectant 
formulation used, the DBS samples collected on Fluka paper showed significant 
losses in the level of all LCPUFA (Table 3).  The levels of n-3 LCPUFA in DBS 
collected on Fluka paper were significantly lower than the corresponding baseline 
values obtained from fresh blood as early as 2 weeks after collection, and continued to 




Different protectant formulations showed different stabilising ability in regard to DBS 
collected on Whatman ion exchange paper. The blood spot samples treated with 
2mg/ml BHT alone exhibited significant declines in the level of EPA+DHA after only 
2 weeks of storage when compared with the baseline values obtained from fresh blood 
(Figure 4b).  However, when 5mg/ml of either of the chelating agents (L-ascorbic acid, 
citric acid or EDTA) was added to the BHT impregnated Whatman ion exchange 
paper, the levels of all LCPUFA in the DBS samples did not differ significantly from 
the baseline values even after 9 weeks of storage at room temperature (Table 3).   
 
Clinical Validation of our DBS method  
There were no significant differences in the mean levels of any of the major fatty 
acids of interest between the capillary DBS and venous whole blood total lipids 
(Table 4) confirming that capillary DBS was representative of venous blood in 
relation to fatty acid composition.  As expected, there were differences in the levels of 
most fatty acids between the whole blood sample (capillary DBS and venous whole 
blood total lipids) and those in the blood fractions (plasma total lipids, plasma 
phospholipids, and erythrocyte phospholipids). The only exception was EPA, which 
did not exhibit any significant differences between different sample types (Table 4). 
 
The fatty acid results from capillary DBS were strongly and significantly correlated 
with those obtained using conventional measurements (Table 5). Of all the fatty acids 
evaluated, the n-3 LCPUFA (EPA, DPA and DHA) in capillary DBS samples 
exhibited the strongest correlation with the corresponding fatty acids from each of the 
respective blood fractions measured by conventional assays (Table 5). There was a 
particularly tight relationship between EPA (r
 
= 0.998) and DHA (r
 
= 0.996) levels 
measured using the capillary DBS assay and conventional assay of venous whole 
blood (Table 5, Figure 5).  
 
Correlations of n-3 biomarkers, including the omega-3 Index (sum of EPA+DHA% in 
erythrocyte phospholipids), AA/EPA ratio, and n-6/n-3 ratio were also compared 
between capillary DBS and whole blood total lipids, plasma total lipids, plasma 
phospholipids, and erythrocyte phospholipids. In general, values for n-3 biomarkers 
obtained from capillary DBS were strongly correlated with those from conventional 
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measurements (r >0.9) (Table 5). Furthermore, the EPA+DHA content in the capillary 
DBS was significantly correlated (r = 0.972) with the omega-3 index which is an 
accepted biomarker for the risk of coronary heart disease [4] (Figure 5). 
 
Stability of fatty acids in other bio-fluids collected as dried spots 
50µl of plasma or breast milk was collected using the Fluka collection kit (Fluka 
paper + 0.5mg/ml BHT) and our newly developed system (Whatman ion exchange 
paper + 2mg/ml BHT+ 5mg/ml EDTA). Plasma spots and breast milk spots were 
analysed for fatty acid status following the same procedure as for the DBS either 
immediately after air drying (5 hrs), or after 1 week, 2 weeks or 4 weeks storage at 
room temperature in cellophane bags as previously described.  
 
The plasma spots collected on Fluka blood collection kit showed significant losses of 
EPA and DHA after 2 weeks of storage at room temperature (Figure 6a), and after 4 
weeks of storage there was an ~20% reduction of all n-3 LCPUFA levels in the 
plasma collected on commercial collection paper when compared with direct 
transesterification of 50 µl fresh plasma (Table 3). However, there was no significant 
change in the fatty acid composition of plasma spots collected using our protection 
system over 4 weeks of storage at room temperature (Table 3).  
 
In relation to the breast milk spots, irrespective of the protection system used, there 
was no significant difference in fatty acid composition in breast milk spots over 4 
weeks of storage at room temperature (Figure 6b, Table 4). 
 
Discussion and conclusions 
DBS technology is increasingly being used in a variety of applications including 
newborn screening, epidemiological studies, and therapeutic drug monitoring [18-20]. 
The potential usefulness of DBS lies in the ability to undertake analyses using a small 
volume of capillary blood taken by auto-lancets rather than syringes, and ease of 
storage and transport. The system is reliant on the fact that the compounds to be 
measured are either completely stable on the collection paper or break down to a 
stable metabolite that can be readily measured. Previously reported DBS assays for 
the evaluation of LCPUFA status of individuals [7, 8] have been found to lack 
efficiency in stabilising LCPUFA [11, 15]. This is almost certainly due to the fact that 
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spotting blood on filter paper naturally exposes the LCPUFA in blood to the air, 
resulting in oxidation of the LCPUFA, and this process can be enhanced by the 
liberation of iron contained in blood haemoglobin during air drying [21, 22]. 
 
Many of the reports claiming stable DBS methodology in profiling fatty acids are 
flawed by the use of inappropriate controls or using bloods with low levels of n-3 
LCPUFA so that small changes would not have been detected [7, 8, 11, 14, 15]. Some 
studies [7, 11, 15] have taken as their zero time point a sample of blood that has been 
recently spotted onto filter paper and dried in air, a process we have shown here to 
result in significant losses in n-3 LCPUFA even in the presence of an antioxidant 
(Table 1). Two studies [8, 14] claimed that their baseline blood spot samples were 
processed immediately at time zero, however, the actual air drying times were not 
indicated or controlled for. It is important to emphasise that our study used the fatty 
acid values from direct transesterification of 50µl of whole blood (that is, blood added 
directly to a tube containing transesterification reagent) immediately after phlebotomy 
as a baseline control for all of our studies, a process that ensures an accurate measure 
of original blood levels of n-3 LCPUFA [23]. Furthermore, we chose to conduct many 
of our experiments on blood from an individual who was a long time consumer of 
high dose fish oil to deliberately subject our methodology to the magnification of 
having high blood levels (>15%) of n-3 LCPUFA. This is contrast to other reports [11, 
14] where the blood n-3 LCPUFA levels are only ~5% of the total fatty acids, such 
that small decreases in n-3 LCPUFA would be hard to detect. 
 
Our study revealed that a combination of  three components are necessary  to ensure 
the stability of LCPUFA in blood spot samples during air drying and long term 
storage at room temperature: an antioxidant (BHT),  a chelating agent (EDTA) and 
silica gel coated paper (Whatman ion exchange paper). This is consistent with 
previous studies which have shown that protection systems consisting of both 
antioxidant and chelating agents performed much better than systems which use 
antioxidant alone for protecting PUFA in avocado [24] and fish oil [25], and also 
vitamin A palmitate in ultra rice [26] from oxidation during storage. The mechanisms 
involved by which all three components achieve optimal stability of LCPUFA can be 




Antioxidants are frequently used in inhibiting the oxidation of lipids because they 
compete with lipids for oxidation, and stop the propagation of free radicals by 
undergoing oxidation to produce stable and relatively unreactive antioxidant radicals 
[27]. Fatty acids bind strongly to silica gel particles aiding their stability in 
chromatographic situations. Studies have shown that lipid oxidation rates are reduced 
with decreasing water activity on the surface of lipids [28, 29]. Thus, silica gel coated 
paper may diminish the lipid oxidation rate by reducing the water activity close to the 
water monolayer on the surface of dried blood spot [30]. 
 
The use of a chelating agent in our study was not accidental, but based on the 
hypothesis that by binding the iron ion in blood with chelators, it would be possible to 
greatly retard iron-mediated LCPUFA losses from DBS samples. This hypothesis is 
based on the known role of iron ions as oxidisers, and the fact that the liberation of 
iron from haemoglobin during air drying [31] enables the rapid catalysis of 
degradation of unsaturated lipids either by direct initiation and formation of lipid 
peroxyl and alkyl radicals, or by inducing the production of hydroxyl radicals through 
a Fenton reaction [32, 33]. The key property shared by all chelating agents is that they 
are able to bind iron ions very tightly, thereby rendering them chemically inert [33]. A 
study of lipid peroxidation in heart cells showed that iron loading led to significant 
reductions in the levels of LCPUFA in liposomal vesicles [34]. These changes were 
identical to those reported in previous studies of the fatty acid composition of RBC 
membrane lipids in beta-thalassemia, a disease in which iron overload is frequently 
observed in the blood [35].  
 
The fatty acid levels measured using our novel DBS method in 50 subjects consuming 
a range of omega 3 fats were closely related not only to levels measured in whole 
blood, but also to levels in all blood fractions that were assessed. This is not 
unexpected given previous reports of strong correlations of individual fatty acid levels 
between blood fractions [22, 24], which is thought to be due to the exchange of fatty 
acids in phospholipids between plasma and other cell types, in particular the 
erythrocytes [25]. We found that these relationships were particularly strong for EPA 
and DHA (r >0.95), which are considered to be the most reliable indicators of n-3 
LCPUFA status in relation to disease risks [36]. In addition, established biomarkers of 
disease risk, including the omega-3 index and the AA/EPA ratio, obtained using our 
15 
 
DBS system were also closely correlated with those obtained using conventional 
measures. Whilst previous DBS studies [9, 10, 17] have reported strong correlations 
between the fatty acid levels obtained from the capillary DBS and conventional blood 
fractions, these studies were all conducted in populations with a relatively narrow 
range of whole blood n-3 LCPUFA content (EPA+DHA%, from 2.0 to 6.0). The 
present study demonstrates that these relationships extend to a much wider range of 
whole blood n-3 LCPUFA content (EPA+DHA%, from 2.0 to 20.0). The close 
relationships identified between our DBS measures of the n-3 LCPUFA and the 
conventional measures therefore validates the suitability of our capillary DBS assay 
for the measurement of fatty acid status in subjects with a wide range of dietary n-3 
fatty acid intakes. Furthermore, these relationships make it possible to develop 
mathematical equations for converting the n-3 results obtained from our DBS system 
to equivalent results for conventional blood fractions in the same subject. This will 
enable researchers to directly compare the n-3 fatty acid status obtained from capillary 
DBS with those of fractions of blood separated by conventional means, and thus to 
relate the DBS results to n-3 fatty acid levels reported in previous studies. 
 
We also compared the stability of LCPUFA in plasma and in breast milk collected 
using our protection system with those collected using the commercially available 
Fluka collection kit. The plasma spots collected using the commercial test kit showed 
a ~20% loss of n-3 LCPUFA after 4 weeks of storage at room temperature, whereas 
the plasma spots collected using our system were stable over the same period. On the 
other hand breast milk was stable in both collection systems. This could be explained 
by the fact that plasma (1~2mg/L) [37] has a higher iron content than breast milk 
(~0.35mg/L) [38]. However, it is important to note that the LCPUFA in both plasma 
spots and breast milk spots collected using our protection system remained stable over 
4 weeks of storage at room temperature (Tables 3, 4). This indicates that our 
protection system may be suitable for protecting the LCPUFA in variety of bio-fluids, 
including plasma, breast milk, and possibly saliva.  
 
In conclusion, we have developed a three component protection system comprising an 
antioxidant, a chelating agent, and silica gel coated paper which can prevent LCPUFA 
in blood spots from significant oxidative loss for at least 2 months when stored at 
room temperature. This system has the potential to allow accurate evaluation of fatty 
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acid status in DBS samples after long term storage and thus enable comparisons 
between samples which have been stored for different periods of time. The DBS test 
offers significant advantages over conventional methods for assessing fatty acid status 
in large clinical trials and population screening programs. It is because the capillary 
DBS assay does not necessitate the involvement of professional operators in blood 
sampling, and considerably reduces the analytical time and cost when compared with 
conventional blood fatty acid assays. Furthermore, since the LCPUFA in DBS are 
stable at room temperature, the use of this system elimates the cost and logistical 
problems involved in transporting samples that need refrigeration or freezing between 
clinical sites and diagnostic laboratories. The clinical data presented in this study 
further validate our DBS methodology by demonstrating that the results obtained 
using this approach can be directly related to those obtained by conventional methods. 
Our DBS method thus has significant potential for the application in large-scale 
clinical or epidemiological studies focused on the role of n-3 fatty acids consumption 
in human health. 
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Figure 1. Stability of LCPUFA in blood spots on 4 types of collection papers 
impregnated with 0.5mg/ml BHT over 4 weeks storage at room temperature. Values 
are presented as mean ± SD (n=3 per time point), different superscripts indicate 
significant differences between treatments, p<0.01. Baseline refers to the fatty acid 
composition obtained from direct transmethylation of 50 µl fresh blood at time zero. 
 
Figure 2. EPA+DHA% of DBS on Fluka paper or Whatman ion exchange paper in the 
presence or absence of single antioxidant determined after 4 weeks storage at room 
temperature. Values are presented as mean ± SD (n=3 per time point), different 
superscripts indicate significant differences between treatments, p<0.01. Baseline 
refers to the fatty acid composition obtained from direct transmethylation of 50 µl 
fresh blood at time zero. 
 
Figure 3. EPA+DHA% of DBS on Fluka paper or Whatman ion exchange paper in the 
presence or absence of single chelating agent  determined after 4 weeks storage at 
room temperature. Values are presented as mean ± SD (n=3), different superscripts 
indicate significant differences between treatments, p<0.01. Baseline refers to the 
fatty acid composition obtained from direct transmethylation of 50 µl fresh blood at 
time zero. 
 
Figure 4. EPA+DHA% in DBS on Fluka paper (a) or Whatman ion exchange paper (b) 
determined over 9 weeks storage at room temperature. Values are presented as mean 
± SD (n=3). Baseline refers to the fatty acid composition obtained from direct 
transmethylation of 50 µl fresh blood at time zero. Data obtained from table 1 and 2.   
 
Figure 5. Correlations for EPA+DHA content between capillary DBS and whole 
blood total lipids (A), plasma total lipids (B), plasma phospholipids (C), erythrocyte 
phospholipids (D). TLE, total lipid extract; PL, phospholipids 
 
Figure 6. EPA+DHA% in plasma spots (a) or breast milk spots (b) collected using 
Fluka collection kit or new protection system determined over 4 weeks storage at 
20 
 
room temperatures. Values are presented as mean ± SD (n=3), different superscripts 
indicate significant differences between treatments, p<0.01. Baseline refers to the 
fatty acid composition obtained from direct transmethylation of 50 µl of plasma or 






























































(mean and range) 
Gender 
(M/F) 
High n-3 intake 
(≥3 grams of fish oil/week) 
 
23 56 (24-75) 14/9 
Moderate n-3 intake 
(Seldom fish oil consumption, 
but ≥1 serving of fish/week) 
 
14 42 (23-59) 5/9 
Low n-3 intake 
(Seldom fish oil consumption, 
and<1 serving of fish/week) 
13 35 (23-54) 5/8 
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Table 2. Fatty acid composition of blood spots on two types of collection paper impregnated with different protectants after 5 hr air drying at 
































































































































16:1 n-7 1.4±0.02 1.4±0.02 1.4±0.02 1.4±0.02 1.4±0.02 1.4±0.02  1.5±0.02 1.4±0.02 1.4±0.02 1.4±0.02 1.4±0.02 
























24:1 n-9 0.8±0.02 0.8±0.01 0.8±0.01 0.8±0.01 0.8±0.01 0.8±0.01  0.8±0.02 0.8±0.02 0.8±0.01 0.8±0.01 0.8±0.02 
18:2 n-6 19.8±0.2
a















































22:4 n-6 0.5±0.01 0.5±0.01 0.5±0.01 0.5±0.01 0.5±0.01 0.5±0.01  0.5±0.01 0.5±0.01 0.5±0.01 0.5±0.01 0.5±0.01 
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Values are presented as mean ± SD (n=3), different superscripts indicate significant differences between treatments, p<0.01. 
                                                                 2
Baseline refers to the fatty acid composition obtained from direct transmethylation of 50 µl fresh blood at time zero. 


































































































































































































































































































































































































        
  1
Values are presented as mean ± SD (n=3), different superscripts indicate significant differences between treatments, p<0.01. 
                                                                 2
Baseline refers to the fatty acid composition obtained from direct transmethylation of 50 µl fresh blood at time zero. 
                                          *BHT was used at a concentration of 2mg/ml, citric acid, L-ascorbic acid, and EDTA were used at a concentration of 5mg/ml. 
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Table 4. Fatty acid profiles of lipids in 50 subjects measured from capillary DBS, 
venous whole blood, plasma and erythrocytes 
Fatty acids Capillary DBS 
Whole blood 
TLE 













































































































































































































Values in the same row with different superscripts indicate values which are significantly different 
between groups, P<0.01.  
SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.; 
TLE, total lipid extract; PL, phospholipid
25 
 
Table 5. Correlation for fatty acid composition between capillary DBS and 
conventional assays  
Capillary DBS  
fatty acids 
Corresponding fatty acids in venous blood fractions
a
 








16:0 0.961** 0.962** 0.771** 0.626** 
18:0 0.938** 0.843** 0.551** 0.7** 
16:1 n-7 0.946** 0.878** 0.623** 0.511* 
18:1 n-9 0.982** 0.971** 0.463* 0.674** 
18:2 n-6 (LA) 0.991** 0.854** 0.896** 0.824** 
18:3 n-3 (ALA) 0.951** 0.927** 0.578** 0.441* 
20:4 n-6 (AA) 0.993** 0.85** 0.693** 0.754** 
20:5 n-3(EPA) 0.998** 0.995** 0.988** 0.973** 
22:4 n-6 0.980** 0.587** 0.436* 0.889** 
22:5 n-3 (DPA) 0.915** 0.878** 0.838** 0.847** 
22:6 n-3(DHA) 0.996** 0.976** 0.964** 0.971** 
EPA+DHA 0.996** 0.982** 0.962** 0.972** 
AA/EPA 0.993** 0.970** 0.974** 0.955** 
n-6 FA/n-3 FA 0.993** 0.936** 0.927** 0.925** 
TLE, total lipid extract; PL, phospholipids 
a Spearman’s rank correlation coefficient 


















Table 6. Fatty acid composition of plasma spots collected using Fluka collection kit or 






New protection system  Fluka collection kit 




































































22:4 n-6 0.6±0.02 0.6±0.02 0.6±0.02  0.5±0.02 0.5±0.02 













Values are presented as mean ± SD (n=3), different superscripts indicate significant differences   
between treatments, p<0.01. 
2
Baseline refers to the fatty acid composition obtained from direct transmethylation of 50 µl fresh    
plasma at time zero. 
 
Table 7. Fatty acid composition of breast milk spots collected using Fluka collection 






New protection system  Fluka collection kit 
2 weeks 4 weeks  2 weeks 4 weeks 
16:0 30.2±0.2 30.3±0.1 30.3±0.1  30.5±0.2 30.5±0.2 
18:0 8.1±0.1 8.2±0.1 8.1±0.1  8.3±0.1 8.3±0.1 
18:1 n-9 43.1±0.3 43.4±0.2 43.4±0.1  43.4±0.1 43.3±0.1 
18:2 n-6 15.1±0.1 14.7±0.1 14.8±0.1  14.7±0.1 14.6±0.1 
18:3 n-3 2.1±0.1 2.0±0.04 2.1±0.01  2.0±0.03 1.9±0.04 
20:4 n-6 0.09±0.00 0.09±0.00 0.08±0.00  0.08±0.00 0.08±0.00 
20:5 n-3 0.5±0.01 0.5±0.02 0.5±0.01  0.5±0.01 0.5±0.01 
22:4 n-6 0.1±0.01 0.1±0.01 0.1±0.01  0.1±0.01 0.1±0.01 
22:5 n-3 0.1±0.00 0.1±0.00 0.1±0.01  0.1±0.00 0.1±0.00 
22:6 n-3 0.2±0.01 0.2±0.01 0.2±0.01  0.2±0.01 0.2±0.01 
1
Values are presented as mean ± SD (n=3), no significant differences were found between treatments 
for any of the fatty acids, p<0.01. 
2
Baseline refers to the fatty acid composition obtained from direct transmethylation of 50 µl fresh 
breast milk at time zero.   
 
